Bio-Rad Laboratories (BIO) Accumulated Expenses (2009 - 2026)

Bio-Rad Laboratories (BIO) has 18 years of Accumulated Expenses data on file, last reported at $148.4 million in Q1 2026.

• On a quarterly basis, Accumulated Expenses fell 5.72% year-over-year to $148.4 million in Q1 2026; TTM through Mar 2026 was $148.4 million, a 5.72% decrease from a year earlier, with the FY2025 full-year figure at $172.3 million, up 38.73% from the prior year.
• Accumulated Expenses for Q1 2026 stood at $148.4 million, down from $172.3 million in the prior quarter.
• Over the last five years, Accumulated Expenses for BIO reached as high as $194.8 million in Q4 2022 and fell as low as $124.2 million in Q4 2024.
• Historically, Accumulated Expenses has averaged $161.4 million across 5 years, with a median of $157.4 million in 2025.
• Across the five-year window, Accumulated Expenses slipped 29.68% in 2022 and jumped 38.73% in 2025, its largest moves.
• Year by year, Accumulated Expenses stood at $194.8 million in 2022, then declined by 28.18% to $139.9 million in 2023, then dropped by 11.22% to $124.2 million in 2024, then jumped by 38.73% to $172.3 million in 2025, then retreated by 13.87% to $148.4 million in 2026.
• Per Business Quant data, the three most recent Accumulated Expenses figures were $148.4 million in Q1 2026, $172.3 million in Q4 2025, and $182.8 million in Q3 2025.